Neumora Therapeutics Inc. [NMRA] stock prices are down -3.49% to $12.45 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NMRA shares have gain 7.24% over the last week, with a monthly amount glided 35.33%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Neumora Therapeutics Inc. [NASDAQ: NMRA] stock has seen the most recent analyst activity on July 22, 2024, when Needham initiated its Buy rating and assigned the stock a price target of $23. Previously, Mizuho started tracking the stock with Outperform rating on July 08, 2024, and set its price target to $20. On December 12, 2023, Deutsche Bank initiated with a Hold rating and assigned a price target of $13 on the stock. William Blair started tracking the stock assigning a Outperform rating and suggested a price target of $26 on October 10, 2023. Stifel initiated its recommendation with a Buy and recommended $26 as its price target on October 10, 2023. RBC Capital Mkts started tracking with a Outperform rating for this stock on October 10, 2023, and assigned it a price target of $24. In a note dated October 10, 2023, JP Morgan initiated an Overweight rating and provided a target price of $21 on this stock.
The stock price of Neumora Therapeutics Inc. [NMRA] has been fluctuating between $8.33 and $21.00 over the past year. Currently, Wall Street analysts expect the stock to reach $24.5 within the next 12 months. Neumora Therapeutics Inc. [NASDAQ: NMRA] shares were valued at $12.45 at the most recent close of the market. An investor can expect a potential return of 96.79% based on the average NMRA price forecast.
Analyzing the NMRA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -1.14 and Total Capital is -0.64. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.08 points at the first support level, and at 11.72 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.90, and for the 2nd resistance point, it is at 13.36.
Ratios To Look Out For
It’s worth pointing out that Neumora Therapeutics Inc. [NASDAQ:NMRA]’s Current Ratio is 17.99. In addition, the Quick Ratio stands at 17.99 and the Cash Ratio stands at 7.43.
Transactions by insiders
Recent insider trading involved Burow Kristina, Director, that happened on Nov 14 ’23 when 3357.0 shares were purchased. 10% Owner, ARCH Venture Partners XII, LLC completed a deal on Nov 14 ’23 to buy 3357.0 shares. Meanwhile, 10% Owner ARCH Venture Partners XII, LLC bought 31653.0 shares on Nov 13 ’23.
